140
Participants
Start Date
January 19, 2023
Primary Completion Date
March 31, 2024
Study Completion Date
March 31, 2024
No Intervention
This is an observational study to assess the incidence and key disease characteristics of symptomatic acute respiratory viral infections in a high-risk population at risk for poor outcomes. Duration of each participant will be up to 12 months.
Henry Ford Hospital, Detroit
Stanford Hospital and Clinics, Palo Alto
Fred Hutchinson Research Center, Seattle
Hamilton Health Sciences, Hamilton
Janssen Research & Development, LLC
INDUSTRY